Intestinal Bacteria Flora Disturbance Clinical Trial
— MARCOfficial title:
Prevalence Study Evaluating the Acquisition of Carriage of Resistant Bacteria in the Gut Flora in Volunteers From French Armed Forces Coming Back From External Operations
Prevalence Study evaluating the acquisition of carriage of multidrug-resistant Gram-negative bacteria (MDRGNB) in the gut flora in volunteers of French Armed Forces staying from 4 to 6 months outside France.
Status | Completed |
Enrollment | 272 |
Est. completion date | December 2013 |
Est. primary completion date | December 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Being older than 18 years - Have given an informed consent by signing the written consent - Being able to give a stool sample - Being member of military forces, supported medically by the French Military Health Services (SSA), and to participate outside mission during 4- 6 months Exclusion Criteria: - Participating in another biomedical study during the study - Volunteer unable to give informed consent. |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
France | Centre d'épidémiologie et de santé publique des armées | Saint Mandé cedex |
Lead Sponsor | Collaborator |
---|---|
Da Volterra |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Frequency of MDRGNB (ESBLs or carbapenemases) colonization in gut flora of volunteers after staying 4-6 months outside France | 12 months | No | |
Secondary | Quantitative measurement of MDRGNB in fecal samples (expressed as log10 and percentage) of volunteers after staying 4-6 months outside France | 12 months | No | |
Secondary | Quantitative variation of MDRGNB between the departure and return in volunteers | 12 months | No | |
Secondary | PCR and sequencing of resistance genes from strains of interest | 12 months | No | |
Secondary | Evaluation of risk factors for acquiring MDRGNB in gut flora of volunteers after staying 4-6 months outside France | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02538211 -
The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
|
N/A | |
Completed |
NCT02220439 -
Does the Fecal Microbiome Influence Rotarix Immunogenicity
|
N/A | |
Completed |
NCT02539836 -
Study on Dietary Nutrition Intervention Techniques for Children Obesity
|
N/A | |
Recruiting |
NCT05461508 -
Fucoidan Assisted Eradication of Helicobacter Pylori
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667404 -
Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study
|
Phase 2 | |
Completed |
NCT02318134 -
Fecal Microbiota Transplantation for Pancreatitis
|
Phase 2 | |
Recruiting |
NCT04672889 -
Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis
|
N/A | |
Completed |
NCT03770143 -
Evaluation of the Effect of Palm Olein Free Formula on Intestinal Flora and Gastrointestinal Tolerance
|
||
Completed |
NCT03103958 -
Effects of Probiotic on Modulation of the Intestinal Microbiota in Constipated Patients
|
N/A | |
Not yet recruiting |
NCT05658055 -
The Effect of Probiotics on Gut Microbiotain After Helicobacter Pylori Eradication
|
Phase 4 | |
Recruiting |
NCT03018613 -
Fecal Microbiota Transplantation for Chronic Functional Constipation
|
Phase 1/Phase 2 | |
Recruiting |
NCT03016780 -
Fecal Microbiota Transplantation for Ulcerative Colitis
|
Phase 1/Phase 2 | |
Recruiting |
NCT03015467 -
Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis(SAP)
|
Phase 1/Phase 2 | |
Completed |
NCT05016999 -
Allium Extracts on the Intestinal Microbiota in Healthy Resident Volunteers.
|
N/A | |
Completed |
NCT02377063 -
The Effect of Fruit/Vegetable Drinks on the Human Intestine
|
N/A |